MYCN and cancer: From these results, we set the following four classes for machine learning analysis (Fig. 1B): Group A, patients with MYCN amplification; Group B, INSS stage IV cancer patients without MYCN amplification; Group C: INSS stage IVs cancer patients; and Group D: INSS stage I, II, and III patients without MYCN amplification.